Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

MGNX

Macrogenics Inc

May 13 • 04:00PM ET

4.38

Dollar change +1.07
Percentage change 32.33	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: VTI VXF IWM VTWO VHT IBB IWN VFMO SCHA LABU

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.38	Insider Own	6.45%	Shs Outstand	62.07M	Perf Week	-73.24%
Market Cap	274.01M	Forward P/E	-	EPS next Y	-1.89	Insider Trans	-6.78%	Shs Float	58.52M	Perf Month	-75.03%
Income	-23.24M	PEG	-	EPS next Q	-0.70	Inst Own	93.14%	Short Float	17.03%	Perf Quarter	-75.56%
Sales	43.36M	P/S	6.32	EPS this Y	-1850.91%	Inst Trans	-8.39%	Short Ratio	4.94	Perf Half Y	-33.13%
Book/sh	1.70	P/B	2.58	EPS next Y	35.59%	ROA	-7.85%	Short Interest	9.96M	Perf Year	-36.24%
Cash/sh	2.95	P/C	1.49	EPS next 5Y	-	ROE	-21.58%	52W Range	3.14 - 21.88	Perf YTD	-54.47%
Dividend Est.	-	P/FCF	-	EPS past 5Y	48.88%	ROI	-17.08%	52W High	-79.98%	Beta	2.05
Dividend TTM	-	Quick Ratio	3.61	Sales past 5Y	15.77%	Gross Margin	64.67%	52W Low	39.49%	ATR (14)	1.80
Dividend Ex-Date	-	Current Ratio	3.63	EPS Y/Y TTM	75.19%	Oper. Margin	-423.39%	RSI (14)	21.16	Volatility	21.89% 9.94%
Employees	339	Debt/Eq	0.32	Sales Y/Y TTM	-73.78%	Profit Margin	-53.60%	Recom	1.75	Target Price	13.90
Option/Short	Yes / Yes	LT Debt/Eq	0.28	EPS Q/Q	-36.25%	Payout	-	Rel Volume	9.66	Prev Close	3.31
Sales Surprise	-38.74%	EPS Surprise	-30.72%	Sales Q/Q	-62.83%	Earnings	May 09 AMC	Avg Volume	2.02M	Price	4.38
SMA20	-70.68%	SMA50	-72.77%	SMA200	-57.33%	Trades		Volume	19,459,053	Change	32.33%

Date	Action	Analyst	Rating Change	Price Target Change
May-10-24	Downgrade	TD Cowen	Buy → Hold
May-10-24	Downgrade	Stifel	Buy → Hold	$29 → $7
May-10-24	Downgrade	BMO Capital Markets	Outperform → Market Perform	$24 → $8
Apr-26-24	Initiated	B. Riley Securities	Buy	$25
Apr-09-24	Upgrade	TD Cowen	Hold → Buy
Mar-04-24	Reiterated	BTIG Research	Buy	$12 → $24
Feb-14-24	Downgrade	H.C. Wainwright	Buy → Neutral	$12 → $14
Dec-20-23	Upgrade	Citigroup	Neutral → Buy	$7 → $13
Nov-07-23	Upgrade	Guggenheim	Neutral → Buy	$12
Mar-17-23	Downgrade	Guggenheim	Buy → Neutral
Nov-22-22	Downgrade	Cowen	Outperform → Market Perform
Nov-14-22	Upgrade	BMO Capital Markets	Market Perform → Outperform	$5.70 → $16
Jul-18-22	Downgrade	SMBC Nikko	Outperform → Neutral	$5
Jul-11-22	Downgrade	BMO Capital Markets	Outperform → Market Perform	$31 → $4
May-04-22	Downgrade	Guggenheim	Buy → Neutral
Feb-28-22	Upgrade	Citigroup	Neutral → Buy	$23 → $21
Feb-11-22	Initiated	BMO Capital Markets	Outperform	$31
Feb-04-22	Initiated	SMBC Nikko	Outperform	$40
Nov-17-21	Resumed	Guggenheim	Buy	$30
Oct-19-21	Initiated	JMP Securities	Mkt Outperform	$39

Show Previous Ratings

Today 12:30PM	MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study Hagens Berman (GlobeNewswire) +32.33%
07:30AM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
May-10-24 06:01PM	MacroGenics (MGNX) Stock Crashes After Reporting Patient Deaths in TAMARACK Study Hagens Berman (GlobeNewswire) -77.44%
04:51PM	Macrogenics Stock Drops 77% After Study Deaths (The Wall Street Journal)
03:29PM	Macrogenics Inc (MGNX) Q1 2024 Earnings: Misses Revenue Estimates Amidst Ongoing Clinical ... (GuruFocus.com)
03:17PM	Loading…
03:17PM	MacroGenics, Inc. (NASDAQ:MGNX) Q1 2024 Earnings Call Transcript (Insider Monkey)
02:01PM	Top Midday Decliners (MT Newswires)
08:35AM	Why Is Macrogenics (MGNX) Stock Down 69% Today? (InvestorPlace)
07:48AM	Top Premarket Decliners (MT Newswires)
07:30AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
07:15AM	BMO Downgrades MacroGenics to Market Perform From Outperform, Price Target at $8 (MT Newswires)
07:14AM	Stifel Downgrades MacroGenics to Hold (MT Newswires)
07:12AM	TD Cowen Downgrades MacroGenics to Hold From Buy (MT Newswires)
07:12AM	MacroGenics Says Five Patients Died in Cancer Study (MT Newswires)
06:02AM	MacroGenics' stock crashes after 5 deaths seen in ADC trial (FierceBiotech.com)
04:57AM	Loading…
04:57AM	MacroGenics Q1 Loss Widens, Revenue Falls (MT Newswires)
02:15AM	MacroGenics (MGNX) Q1 2024 Earnings Call Transcript (Motley Fool)
May-09-24 08:57PM	MGNX Stock Earnings: Macrogenics Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
04:10PM	MacroGenics: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data (GlobeNewswire)
May-03-24 07:30AM	MacroGenics Announces Date of First Quarter 2024 Financial Results Conference Call (GlobeNewswire)
May-01-24 10:05AM	Biotech Innovations Aim to Combat Soaring Cancer Diagnoses by 2050 (PR Newswire) +5.21%
Apr-26-24 08:00AM	B. Riley Securities Initiates MacroGenics With Buy Rating, $25 Price Target (MT Newswires)
Apr-03-24 04:30PM	MacroGenics Provides Phase 2 TAMARACK Study Early Interim Safety Data and Plans for Future Disclosures (GlobeNewswire)
Mar-14-24 08:18AM	MacroGenics, Inc. (NASDAQ:MGNX) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-09-24 01:09PM	12 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Mar-08-24 07:19AM	Q4 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents) -15.02%
12:30AM	MacroGenics (MGNX) Q4 2023 Earnings Call Transcript (Motley Fool)
Mar-07-24 10:42PM	Macrogenics Inc (MGNX) Reports Strong Financial Position and Advancements in Cancer Treatment ... (GuruFocus.com)
09:55PM	MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023 (InvestorPlace)
05:30PM	Loading…
05:30PM	MacroGenics (MGNX) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:01PM	MacroGenics Provides Update on Corporate Progress and 2023 Financial Results (GlobeNewswire)
Mar-06-24 11:29PM	Insider Sell: COO Eric Risser Sells 41,159 Shares of Macrogenics Inc (MGNX) (GuruFocus.com)
Mar-01-24 05:48PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire) +6.24%
Feb-29-24 10:00AM	Analysts Estimate MacroGenics (MGNX) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-27-24 05:45PM	MacroGenics Announces Date of Fourth Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Feb-02-24 04:30PM	MacroGenics to Participate in Upcoming Investor Conference (GlobeNewswire)
07:19AM	MacroGenics (MGNX) Surges 6.8%: Is This an Indication of Further Gains? (Zacks)
Jan-15-24 04:51PM	The 3 Most Undervalued Biotech Stocks to Buy in January (InvestorPlace)
Jan-08-24 04:30PM	MacroGenics to Participate in Upcoming Investor Conference (GlobeNewswire) +7.57%
Dec-17-23 12:03PM	7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar (InvestorPlace)
Nov-07-23 10:56AM	Q3 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents) +17.10%
08:59AM	MacroGenics, Inc. (NASDAQ:MGNX) Q3 2023 Earnings Call Transcript (Insider Monkey)
01:15AM	MacroGenics (MGNX) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-06-23 05:12PM	Macrogenics Inc (MGNX) Reports Q3 2023 Earnings: Net Income of $17. ... (GuruFocus.com)
04:27PM	MacroGenics: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and Third Quarter 2023 Financial Results (GlobeNewswire)
Nov-02-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-31-23 04:30PM	MacroGenics Announces Date of Third Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Sep-05-23 07:00AM	MacroGenics Announces Achievement of $15 Million Milestone Related to Gileads Nomination of a Bispecific Research Program (GlobeNewswire)
Aug-31-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Aug-19-23 07:40AM	3 Under-the-Radar Biotech Stocks to Buy in 2023 (Motley Fool)
Aug-14-23 11:19AM	MacroGenics' (MGNX) Shares Jump 19% in One Week: Here's Why (Zacks) -6.24%
Aug-11-23 01:26PM	MacroGenics, Inc. (NASDAQ:MGNX) Q2 2023 Earnings Call Transcript (Insider Monkey)
Aug-10-23 12:33PM	Why Shares of MacroGenics Are Jumping Thursday (Motley Fool) +24.30%
07:01AM	Q2 2023 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-09-23 11:30PM	MacroGenics (MGNX) Q2 2023 Earnings Call Transcript (Motley Fool)
05:50PM	MacroGenics (MGNX) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:52PM	MacroGenics: Q2 Earnings Snapshot (AP Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-31-23 05:35PM	MacroGenics Announces Date of Second Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Jul-05-23 11:55AM	MacroGenics (NASDAQ:MGNX) shareholders have endured a 83% loss from investing in the stock three years ago (Simply Wall St.)
Jun-28-23 08:12AM	AdaptHealth Corp. (AHCO) Soars 19.6%: Is Further Upside Left in the Stock? (Zacks)
Jun-08-23 07:27AM	MacroGenics Insider Confidence Rewarded, Stock Hits US$321m Market Cap \ (Simply Wall St.)
May-14-23 08:09AM	These Analysts Just Made An Incredible Downgrade To Their MacroGenics, Inc. (NASDAQ:MGNX) EPS Forecasts (Simply Wall St.)
May-10-23 12:10PM	MacroGenics, Inc. (NASDAQ:MGNX) Q1 2023 Earnings Call Transcript (Insider Monkey)
12:30AM	MacroGenics (MGNX) Q1 2023 Earnings Call Transcript (Motley Fool)
May-09-23 05:25PM	MacroGenics (MGNX) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:21PM	MacroGenics: Q1 Earnings Snapshot (AP Finance)
04:01PM	MacroGenics Provides Update on Corporate Progress and First Quarter 2023 Financial Results (GlobeNewswire)
May-05-23 08:27AM	MacroGenics, Inc.'s (NASDAQ:MGNX) Share Price Is Matching Sentiment Around Its Revenues (Simply Wall St.)
May-04-23 04:30PM	MacroGenics Announces Date of First Quarter 2023 Financial Results Conference Call (GlobeNewswire)
Apr-25-23 10:01AM	MacroGenics (MGNX) to Report Q1 Results: Wall Street Expects Earnings Growth (Zacks)
Apr-24-23 06:15PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Apr-07-23 08:48AM	Here's Why We're Not Too Worried About MacroGenics' (NASDAQ:MGNX) Cash Burn Situation (Simply Wall St.)
Mar-22-23 01:22PM	MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ (retifanlimab-dlwr) (GlobeNewswire) -5.76%
Mar-20-23 06:59PM	Why MacroGenics Stock Inched Higher on Monday (Motley Fool)
Mar-18-23 02:52AM	MacroGenics, Inc. (NASDAQ:MGNX) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-17-23 06:15PM	Why MacroGenics Stock Tumbled Today (Motley Fool)
Mar-16-23 12:17PM	Why Shares of MacroGenics Climbed Thursday (Motley Fool) +10.25%
07:10AM	Q4 2022 MacroGenics Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-15-23 11:00PM	MacroGenics (MGNX) Q4 2022 Earnings Call Transcript (Motley Fool)
05:35PM	MacroGenics (MGNX) Surpasses Q4 Earnings Estimates (Zacks)
04:01PM	MacroGenics Provides Corporate Update and 2022 Financial Results (GlobeNewswire)
Mar-14-23 12:32PM	Provention (PRVB) Skyrockets 260% on Buyout Offer From Sanofi (Zacks) +9.69%
08:00AM	Synaffix Announces Expansion of ADC Collaboration with MacroGenics (PR Newswire)
Mar-11-23 07:30AM	Analyst Forecasts For MacroGenics, Inc. (NASDAQ:MGNX) Are Surging Higher (Simply Wall St.)
Mar-09-23 03:59PM	Why Shares of MacroGenics Jumped Thursday (Motley Fool) +12.18%
Mar-08-23 05:36PM	MacroGenics Announces Sale of TZIELD Royalty Interest for up to $200 Million (GlobeNewswire) -6.30%
Mar-07-23 06:00PM	MacroGenics Announces Date of Fourth Quarter 2022 Financial Results Conference Call (GlobeNewswire)
Mar-02-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Feb-20-23 09:56AM	Strength Seen in MacroGenics (MGNX): Can Its 25.7% Jump Turn into More Strength? (Zacks)
Feb-17-23 06:27AM	Daily Vickers Top Buyers & Sellers for 02/17/2023 (Argus Research) +25.67%
Feb-14-23 10:01AM	MacroGenics Posts Interim Data From Lorigerlimab Study In Prostate Cancer Patients (Benzinga) -17.48%
Feb-13-23 05:20PM	MacroGenics Announces Preliminary Clinical Results from Single Arm Study of Lorigerlimab in Patients with Metastatic Castration-Resistant Prostate Cancer to be Presented at ASCO Genitourinary Cancers Symposium (GlobeNewswire) +15.25%
Feb-06-23 04:30PM	MacroGenics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Jan-24-23 07:57AM	SurModics (SRDX) Surges 6.1%: Is This an Indication of Further Gains? (Zacks) +6.13%
06:48AM	Daily Vickers Top Buyers & Sellers for 01/24/2023 (Argus Research)
Jan-06-23 06:15PM	MacroGenics (MGNX) Stock Sinks As Market Gains: What You Should Know (Zacks)
Jan-04-23 05:50PM	MacroGenics to Present at the 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire)

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Peters Jeffrey Stuart	Senior VP and General Counsel	Apr 04 '24	Option Exercise	4.82	42,500	204,850	51,395	Apr 08 06:07 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Apr 04 '24	Sale	15.55	51,395	799,148	0	Apr 08 06:07 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Mar 06 '24	Option Exercise	10.90	19,625	213,875	28,520	Mar 08 04:14 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Mar 06 '24	Sale	21.50	19,625	421,938	8,895	Mar 08 04:14 PM
Risser Eric Blasius	Chief Operating Officer	Mar 04 '24	Option Exercise	10.15	15,000	152,250	80,059	Mar 06 04:20 PM
Spitznagel Thomas	Sr VP, Technical Ops	Mar 04 '24	Option Exercise	11.50	10,000	115,000	18,316	Mar 06 04:19 PM
Risser Eric Blasius	Chief Operating Officer	Mar 04 '24	Sale	19.76	41,159	813,501	38,900	Mar 06 04:20 PM
Karrels James	SVP, CFO and Secretary	Mar 04 '24	Sale	20.50	30,000	615,000	171,452	Mar 06 04:18 PM
Spitznagel Thomas	Sr VP, Technical Ops	Mar 04 '24	Sale	20.00	10,000	200,000	8,316	Mar 06 04:19 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 26 '24	Sale	17.22	16,124	277,655	8,895	Feb 28 04:20 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 22 '24	Option Exercise	0.00	26,250	0	35,145	Feb 26 04:27 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 22 '24	Option Exercise	0.00	28,125	0	110,258	Feb 26 04:26 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 15 '24	Option Exercise	0.00	16,670	0	88,004	Feb 20 06:03 PM
Risser Eric Blasius	Chief Operating Officer	Feb 15 '24	Option Exercise	0.00	16,670	0	70,938	Feb 20 06:04 PM
Cilinski Lynn	VP, Controller and Treasurer	Feb 15 '24	Option Exercise	0.00	6,668	0	8,591	Feb 20 06:04 PM
Koenig Scott	President and CEO	Feb 15 '24	Option Exercise	0.00	42,341	0	1,091,977	Feb 20 06:04 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 15 '24	Option Exercise	0.00	13,336	0	13,336	Feb 20 06:05 PM
Spitznagel Thomas	Sr VP, Technical Ops	Feb 15 '24	Option Exercise	0.00	13,336	0	13,336	Feb 20 06:03 PM
Karrels James	SVP, CFO and Secretary	Feb 15 '24	Option Exercise	0.00	15,003	0	206,779	Feb 20 06:04 PM
Eck Stephen L.	Chief Medical Officer	Feb 15 '24	Option Exercise	0.00	16,670	0	16,670	Feb 20 06:41 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 07 '24	Sale	18.00	3,334	60,012	71,334	Feb 07 04:19 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 05 '24	Option Exercise	11.11	76,251	847,355	76,251	Feb 07 04:17 PM
Peters Jeffrey Stuart	Senior VP and General Counsel	Feb 05 '24	Sale	16.50	76,251	1,258,142	0	Feb 07 04:17 PM
Bonvini Ezio	Sr VP, Research & CSO	Feb 01 '24	Sale	15.00	13,316	199,740	74,668	Feb 02 04:21 PM
Bonvini Ezio	Sr VP, Research & CSO	Jan 19 '24	Sale	12.00	13,316	159,792	87,984	Jan 22 04:57 PM
Bonvini Ezio	Sr VP, Research & CSO	Dec 20 '23	Sale	10.08	18,880	190,310	101,300	Dec 21 04:12 PM
BIOTECH TARGET N V	10% Owner	Oct 02 '23	Buy	4.46	150,000	669,585	9,929,963	Oct 04 03:31 PM
BIOTECH TARGET N V	10% Owner	Sep 07 '23	Buy	5.26	200,000	1,052,840	9,779,963	Sep 11 03:39 PM
HURWITZ EDWARD	Director	Aug 30 '23	Buy	4.91	15,000	73,650	33,074	Sep 01 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MGNX

Macrogenics Inc

Upgrade your FINVIZ experience